Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steatosis of Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06528314
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc 2,150
Not applicableStudy completedNCT05861375
What this trial is testing

Liver Biomarkers in Anorexia Nervosa

Who this might be right for
Anorexia Nervosa
Nantes University Hospital 43
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Not applicableStudy completedNCT06552377
What this trial is testing

Ultrasound and Attenuation Imaging

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty LiverNon-alcoholic Steatohepatitis+1 more
Hywel Dda Health Board 97
Not applicableUnknownNCT00471575
What this trial is testing

Fatty Liver in Pregnancy

Who this might be right for
Fatty Liver
Assaf-Harofeh Medical Center
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Post-approval studies (Phase 4)UnknownNCT06218342
What this trial is testing

Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease

Who this might be right for
Type 2 DiabetesNon-Alcoholic Fatty Liver Disease
Sir Run Run Shaw Hospital 156
Not applicableNot Yet RecruitingNCT06739486
What this trial is testing

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more
Assiut University 100
Not applicableNot Yet RecruitingNCT07334639
What this trial is testing

Metabolic Changes Associated With Weight Gain After Treatment of Achalasia

Who this might be right for
Achalasia, Esophageal
Assaf-Harofeh Medical Center 30
Not applicableUnknownNCT06220695
What this trial is testing

A Nutrigenetic Intervention in MASLD

Who this might be right for
NAFLDFatty Liver
Maastricht University 300
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Post-approval studies (Phase 4)Study completedNCT05459701
What this trial is testing

Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
Rehab Werida 50
Not applicableStudy completedNCT03165877
What this trial is testing

Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Universidad de Valparaiso 13
Post-approval studies (Phase 4)Looking for participantsNCT05305287
What this trial is testing

Quantifying Hepatic Mitochondrial Fluxes in Humans

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio 60
Testing effectiveness (Phase 2)Study completedNCT03400163
What this trial is testing

A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis
Bristol-Myers Squibb 3
Not applicableNot Yet RecruitingNCT07777198
What this trial is testing

Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD

Who this might be right for
MAFLD
Beijing Friendship Hospital 2,303
Testing effectiveness (Phase 2)Study completedNCT02006498
What this trial is testing

Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of Malaya 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07632222
What this trial is testing

High-Protein Diet for Improving Alcoholic Fatty Liver Disease

Who this might be right for
Alcohol-associated Fatty Liver Disease
Li Lab,MD 74
Testing effectiveness (Phase 2)Study completedNCT06442137
What this trial is testing

A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease

Who this might be right for
Hepatic SteatosisSymptoms and Signs
Shanghai Municipal Hospital of Traditional Chinese Medicine 70
Not applicableLooking for participantsNCT05477212
What this trial is testing

Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.

Who this might be right for
Permeability; IncreasedNAFLDObesity
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 30
Next Page